Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Favipiravir: A New Medication for the Ebola Virus Disease Pandemic have?
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic has 140 citations in the OpenAlex counts ScholarIQ stores.
When was Favipiravir: A New Medication for the Ebola Virus Disease Pandemic published?
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic has 2014 year in the ScholarIQ index.
What is the open-access status of Favipiravir: A New Medication for the Ebola Virus Disease Pandemic?
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic has closed oa status in the ScholarIQ index.
What is the DOI of Favipiravir: A New Medication for the Ebola Virus Disease Pandemic?
The DOI for Favipiravir: A New Medication for the Ebola Virus Disease Pandemic is on the source record.
What is the PMID of Favipiravir: A New Medication for the Ebola Virus Disease Pandemic?
The PMID for Favipiravir: A New Medication for the Ebola Virus Disease Pandemic is on the source record.
What is the OpenAlex record for Favipiravir: A New Medication for the Ebola Virus Disease Pandemic?
The OpenAlex for Favipiravir: A New Medication for the Ebola Virus Disease Pandemic is on the source record.